China Universal Asset Management Company’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$116K	Buy	42,424 +3,469	+9%	+$11K	0.01%	395
2025 Q4	$144K	Buy	38,955 +3,614	+10%	+$11.7K	0.01%	380
2025 Q3	$93.7K	Sell	35,341 -4,467	-11%	-$8.64K	0.01%	391
2025 Q2	$39.2K	Buy	39,808 +286	+0.7%	+$286	﹤0.01%	432
2025 Q1	$56.9K	Sell	39,522 -2,257	-5%	-$4.16K	0.01%	411
2024 Q4	$91.9K	Buy	+41,779	New	+$97.5K	0.01%	403
2023 Q4	–	Sell	-2,748	Closed	-$2.69K	–	445
2023 Q3	$2.69K	Buy	2,748 +1,507	+121%	+$2.18K	﹤0.01%	421
2023 Q2	$1.73K	Buy	1,241 +203	+20%	+$283	﹤0.01%	435
2023 Q1	$1.65K	Buy	1,038 +289	+39%	+$1.49K	﹤0.01%	438
2022 Q4	$4.67K	Buy	749 +126	+20%	+$901	﹤0.01%	307
2022 Q3	$4K	Buy	+623	New	+$4.28K	﹤0.01%	295